Condition
Bipolar Depression Depressed Phase
Total Trials
6
Recruiting
2
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Completed1
Active Not Recruiting1
Not Yet Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07740694Recruiting
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
NCT07699445Phase 4Not Yet RecruitingPrimary
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
NCT07599124Completed
Effectiveness of Light Therapy Across Seasons
NCT06986460Phase 3RecruitingPrimary
Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression
NCT07463911Active Not Recruiting
Treatment Response In ECT Patients
NCT02707276Not ApplicableTerminatedPrimary
LFMS: Initial Trial in Geriatric Bipolar Depression
Showing all 6 trials